Cite
HARVARD Citation
Budillon, A. et al. (n.d.). 498PPhase I/II study of valproic acid (VPA) and short-course radiotherapy (SCRT) plus capecitabine (CAP) as preoperative treatment in low-moderate risk rectal cancer (V-shoRT-R3). Annals of oncology. p. . [Online].